Cargando…

Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer

The malignant behaviors of solid tumors such as growth, infiltration and metastasis are mainly nourished by tumor neovascularization. Thus, anti-angiogenic therapy is key to controlling tumor progression. Bevacizumab, a humanized anti-vascular endothelial growth factor (VEGF) antibody, plus chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jie, Xu, Xiaobo, Li, Xiao, Li, Yanli, Liu, Guobing, Tan, Hui, Shen, Hua, Shi, Hongcheng, Cheng, Dengfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273882/ https://www.ncbi.nlm.nih.gov/pubmed/27706035 http://dx.doi.org/10.3390/molecules21101308

Ejemplares similares

(99m)Tc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation
por: Liu, Guobing, et al.
Publicado: (2016)

Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy
por: Li, Yanli, et al.
Publicado: (2016)

Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013)

(99m)Tc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE(−/−) mice
por: Tan, Hui, et al.
Publicado: (2017)

Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
por: Hu, Pengcheng, et al.
Publicado: (2019)

External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
por: Chang, Chih-Hsien, et al.
Publicado: (2015)

(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017)

Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021)

Preparation and biodistribution of (188)Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles ((188)Re-folate-CDDP/HSA MNPs) in vivo
por: Tang, Qiu-Sha, et al.
Publicado: (2011)

Correction: Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma
por: Zhou, Jun, et al.
Publicado: (2019)

Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma
por: Zhou, Jun, et al.
Publicado: (2017)

(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018)

Dynamic (68)Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography-computed tomography for the evaluation of pancreatic neuroendocrine tumors: a pilot study
por: Yin, Hongyan, et al.
Publicado: (2023)

Intratumoral Injection of (188)Re labeled Cationic Polyethylenimine Conjugates: A Preliminary Report
por: Kim, Eun-Mi, et al.
Publicado: (2004)

Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma
por: Shih, Ying-Hsia, et al.
Publicado: (2014)

Preparation, Characterization, and Preliminary Imaging Study of [(188)Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis
por: Xu, Tingting, et al.
Publicado: (2022)

A personal acquisition time regimen of (68)Ga-DOTATATE total-body PET/CT in patients with neuroendocrine tumor (NET): a feasibility study
por: Xiao, Jie, et al.
Publicado: (2022)

Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of (68)Ga-DOTATATE in Normal Organs
por: Yin, Hongyan, et al.
Publicado: (2023)

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study
por: Zhao, Zhiting, et al.
Publicado: (2023)

The neutron capture cross sections of 186;187;188 Os and their application to Re/Os cosmochronometer
por: Fujii, Kaori
Publicado: (2009)

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside
por: Lepareur, Nicolas, et al.
Publicado: (2012)

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors
por: Wang, Shyh-Jen, et al.
Publicado: (2019)

Evaluation of Novel (64)Cu-Labeled Theranostic Gadolinium-Based Nanoprobes in HepG2 Tumor-Bearing Nude Mice
por: Hu, Pengcheng, et al.
Publicado: (2017)

Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012)

Bevacizumab combined with re-irradiation in recurrent glioblastoma
por: She, Lei, et al.
Publicado: (2022)

(188)Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates
por: Savio, Eduardo, et al.
Publicado: (2004)

Evaluation of a Proposed Biodegradable (188)Re Source for Brachytherapy Application: A Review of Dosimetric Parameters
por: Khorshidi, Abdollah, et al.
Publicado: (2015)

Radiation Dose to the Occupational Worker during the Synthesis of (188)Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department
por: Thakral, Parul, et al.
Publicado: (2018)

RADIOACTIVE CEMENT OF PMMA AND HAP-Sm-153, Ho-166, OR RE-188 FOR BONE METASTASIS TREATMENT
por: Montaño, Carlos Julio, et al.
Publicado: (2019)

Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of (188)Re radionuclide for cancer therapy
por: Petriev, V. M., et al.
Publicado: (2019)

Localization of Small‐cell Lung Cancer Xenografts with Iodine‐125‐, Indium‐111‐, and Rhenium‐188‐Somatostatin Analogs
por: Hosono, Makoto, et al.
Publicado: (1996)

Morphological Effect of Non-targeted Biomolecule-Modified MNPs on Reticuloendothelial System
por: Li, Xiao, et al.
Publicado: (2015)

MicroRNA‐188 regulates aging‐associated metabolic phenotype
por: Huang, Yan, et al.
Publicado: (2019)

Subject index for volume 188
Publicado: (1992)

Pseudo-188D: Phage Protein Prediction Based on a Model of Pseudo-188D
por: Gu, Xiaomei, et al.
Publicado: (2021)

Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis
por: Xiao, Xian, et al.
Publicado: (2022)

Correction: Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012)

circGFRA1 Enhances NSCLC Progression by Sponging miR-188-3p
por: Yao, Jie, et al.
Publicado: (2020)

Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis
por: Zhang, Shu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_80o67gpl729ekn0a8oua04ekr8